Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1996

Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996;88(7):2648-54.

Magro CM, Crowson AN, Alfa M, Nath A, Ronald A, Ndinya-Achola JO, et al. A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Hum Pathol. 1996;27(10):1066-70.

DelSal G, Loda M, Pagano M. Cell cycle and cancer: critical events at the G1 restriction point. Crit Rev Oncog. 1996;7(1-2):127-42.

Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med. 1996;183(5):2385-90.

Husain AN, Siddiqui MT, Reddy VB, Yeldandi V, Montoya A, Garrity ER. Postmortem findings in lung transplant recipients. Mod Pathol. 1996;9(7):752-61.

Lin J, Chavin KD, Qin L, Ding Y, Bromberg JS. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3. Cell Immunol. 1996;167(2):249-58.

Crowson AN, Magro CM. Basal cell carcinoma arising in association with desmoplastic trichilemmoma. Am J Dermatopathol. 1996;18(1):43-8.

Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation. 1996;62(7):1011-8.

de Sancho M, Lema MG, Amiral J, Rand J. Frequency of antibodies directed against heparin-platelet factor 4 in patients exposed to heparin through chronic hemodialysis. Thromb Haemost. 1996;75(4):695-6.

Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, et al. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood. 1996;88(10):4012-20.